Appistry Media Coverage
Nature Methods - September 27 2013
Ayrris™ and Appistry’s relationship with the Broad Institute are discussed in this technology feature by Vivien Marx, which reviews how cloud computing is aiding research and clinical labs.
St. Louis Business Journal - January 21 2013
St. Louis cloud computing company Appistry is making more inroads into the genomics research and personalized medicine market.
St. Louis Post-Dispatch - November 6 2012
Appistry is profiled by David Nicklaus of the St. Louis Post-Dispatch, exploring the history of Appistry, its place in the St. Louis bio-science industry, and the its direction for the future.
Startup America Partnership - May 1 2012
In an increasingly digital world, today's enterprise faces a choice: capture, store, manipulate and analyze this torrent of digital information; or get passed by those that do.
Gigaom - April 4 2012
Hadoop might well be the platform of choice for large web and commercial applications indeed, it's where most of those companies' big data investments are going but it has its limitations.
Gigaom - March 27 2012
Sultan Meghjji and his colleagues at Appistry are making it easier to take advantage of the insights that can emerge from rapid, in-depth analysis of big data.
The Brainyard - March 27 2012
Dr. Gordon Springer, Associate Professor and Scientific Director of the Bioinformatics Consortium at the University of Missouri explains how Appistry and Ayrris / BIO™ are powering advances in genomics research and bioinformatics at MU.
- March 14 2012
Appistry joins other data management and analytics providers in CRN’s round-up of the 20 most innovative players and thinkers continuing to make waves in the cloud by developing new and important technologies.
- March 12 2012
Mednelspod’s podcast series spotlights Appistry’s Sultan Meghji, who shares his thoughts on the life sciences industry, genomics, sequencing, and advances in (and roadblocks to) personalized medicine.
- March 1 2012
Genome Technology’s in-depth examination of the “state” of personalized medicine features several insights from Appistry vice president, Sultan Meghji. In the article, Meghji shares his take on the cultural, regulatory and technological issues that continue to limit wide-scale adoption and implementation of these new approaches to clinical medicine.